AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2018
Sep 6, 2018
30786_dirs_2018-09-06_878e304a-6a00-44f2-94ac-e9b42a310ab6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-09-04
Reporting Person: TUMOLO ANNETTE (Executive Vice President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-09-04 | Restricted Stock Units | $0 | A | 3000 | Acquired | Bio-Rad A Common Stock (3000) | Direct | |
| 2018-09-04 | Non-Qualified Stock Option (right to buy) | $326.15 | A | 3000 | Acquired | 2028-09-04 | Bio-Rad A Common Stock (3000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 982.3476 | Direct |
Footnotes
F1: Includes 29.0901, 27.0055, 29.0803 and 25.7907 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 9/30/17, 12/31/17, 3/29/18 and 6/29/18, respectively.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13